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Abstract
Background: Copy number variation (CNV) is a major source of genome polymorphism that directly contributes to
phenotypic variation such as resistance to infectious diseases. Lines 63 and 72 are two highly inbred experimental
chicken lines that differ greatly in susceptibility to Marek’s disease (MD), and have been used extensively in efforts
to identify the genetic and molecular basis for genetic resistance to MD. Using next generation sequencing, we
present a genome-wide assessment of CNVs that are potentially associated with genetic resistance to MD.
Methods: Three chickens randomly selected from each line were sequenced to an average depth of 20×. Two
popular software, CNVnator and Pindel, were used to call genomic CNVs separately. The results were combined to
obtain a union set of genomic CNVs in the two chicken lines.
Results: A total of 5,680 CNV regions (CNVRs) were identified after merging the two datasets, of which 1,546 and 1,866
were specific to the MD resistant or susceptible line, respectively. Over half of the line-specific CNVRs were shared by 2
or more chickens, reflecting the reduced diversity in both inbred lines. The CNVRs fixed in the susceptible lines were
significantly enriched in genes involved in MAPK signaling pathway. We also found 67 CNVRs overlapping with 62
genes previously shown to be strong candidates of the underlying genes responsible for the susceptibility to MD.
Conclusions: Our findings provide new insights into the genetic architecture of the two chicken lines and additional
evidence that MAPK signaling pathway may play an important role in host response to MD virus infection. The rich
source of line-specific CNVs is valuable for future disease-related association studies in the two chicken lines.
Keywords: Copy number variation, Chicken, Susceptibility, Marek’s disease, MAPK signaling pathway, Next generation
sequencing
Background
Marek’s disease (MD) is a T cell lymphoma disease of chick-
ens induced by Marek’s disease virus (MDV), an oncogenic
ɑ-herpesvirus [1]. MD is characterized by lesions of visceral
organs and enlarged nerves that can result in death, and
continues to be one of the most serious chronic disease
threats to the poultry industry. Since the early 1970s, the
poultry industry has relied heavily on MD vaccines, which
have greatly eliminated the incidence of MD [2, 3]. Though
successful, the efficacy of vaccines has been compromised
by the unpredictable outbreaks of more virulent field strains.
Improving genetic resistance to MD of chickens is a
desirable and sustainable long-term MD control meas-
ure. To achieve this objective, studies have been carried
out to uncover the genetic variants underlying resistance
to MD. Genome-wide QTL scans have identified a num-
ber of genomic regions associated with the resistance to
MD [4–7]. With modern statistical and genomic tools,
Li et al. [8] reported two loci associated with MD resist-
ance through genome-wide association study (GWAS).
However, the resolution limits of these strategies make it
difficult to identify the underlying causative genes, and
the variants only explain a small proportion of total gen-
etic variation [9], leaving a large part of variation unex-
plained [10]. More recently, Cheng et al. [11] found that
SNPs in allele-specific expression (ASE) genes captures
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more than 83 % of the additive genetic variation of MD
resistance, demonstrating that the most of the ASE
genes are strong candidates of underlying genes of MD
resistance. However, the causative mutations and
affected pathways are still illusive.
Copy number variations (CNVs) are a type of genomic
polymorphisms characterized by gains or losses of DNA
copies that usually extend from 1 Kb to several million
bases in length and, thus, are believed to have a great im-
pact on phenotypes. Accumulating evidences suggest that
CNVs are responsible for a number of genetic disorders
and susceptibility to infectious diseases [12, 13], and prob-
ably contribute to a fraction of “missing heritability”
[10, 14].
In this study, we applied deep sequencing on two
experimental inbred chicken lines (Avian Disease and
Oncology Laboratory line 63 and 72; ADOL) that differ
substantially in susceptibility to MD. We hypothesized
that resistance to MD is genetically controlled by some
CNVs between these lines. A main focus of this study
was on the detection of deletions, as this type of CNV is
frequently associated with genetic disorders and infectious
diseases in both human and animals [12, 15, 16]. Our ana-
lysis provides new insight of the genetic architecture of
the two inbred lines and the identified CNVs are a rich
resource of variation for future association studies.
Methods
Chicken samples
Chickens from two highly inbred chicken lines maintained
in Avian Disease and Oncology Laboratory (ADOL) (line
63 and line 72) were used in this study. The two lines share
the same major histocompatibility complex (MHC) haplo-
type (B2) [17–19], which is a major locus influencing MD
incidence, yet differ significantly in susceptibility to MD
(lines 63 and 72 are MD resistant and susceptible, respect-
ively). Three chickens from each line (designated RES1,
RES2, RES3 from line 63 and SUS1, SUS2, SUS3 from
line72) were randomly selected for blood collection. The
procedure of collecting blood samples of all animals were
carried out followed the ADOL Animal Care and Usage
Committee policy.
Library construction and sequencing
Genomic DNAs were extracted from blood by standard
phenol/chloroform method [20] and then measured for
concentration and purity by NanoDrop (Thermo Fisher
Scientific Inc. Waltham, MA, USA). Genomic DNAs
were sheared to yield an average size of 500 bp and then
ligated to Illumina (Illumina Inc., San Diego, CA, USA)
paired-end adaptors. After PCR amplification and purifi-
cation, the resultant DNA clusters were sequenced on an
Illumina HiSeq 2000 sequencer (Illumina Inc.). Raw reads
of 2 × 100 bp were generated for downstream analysis.
Read mapping and CNV calling
Low quality reads were removed as previously described
[21]. Mapping reads to the reference genome (galGal4)
was performed with BWA-MEM [22], using default pa-
rameters. Removal of duplicated reads, realignment of
reads around insertion and deletions were performed as
previously described [21].
CNVnator (ver 0.3) [23] based on read depth (RD)
method was used to predict genomic CNVs between the
two chicken lines and the reference. The CNV calling pipe-
line employed here has been previously described [24], with
slight modifications; to improve detection accuracy, only
reads with quality score of 20 (Q20) or higher were used.
To improve detection sensitivity, we used another software
employing split-read approaches, Pindel (ver 0.2.5a4), [25]
to detect medium to large structural variations (SV). The
minimal mapping quality of the reads that Pindel uses as
anchor was set to 20 (parameter “A”) and the maximum
size of SV to be detected was set to 32,628 bp (parameter
“x”). Other parameters were set to default.
To retain confident CNV calls for downstream analysis,
we applied stringent filtering for raw CNV results. For
CNVs called by CNVnator, only significant CNVs (P <
0.01) with a minimum size of 1 kb were retained. CNVs
located on random contigs (chrN_random), unlocalized
chromosomes (chrUn), or in overlapping gaps were dis-
carded. For each SV predicted by Pindel, we required a
minimum of 5 uniquely mapped reads supporting the
variation. Similarly, variations on random contigs and un-
localized chromosomes were excluded from the analysis.
Gene content and functional analysis
Results from CNVnator and Pindel were combined to
obtain a collective set (union) of unique CNVs with dif-
ferent start or end coordinates. These CNVs were then
merged into non-overlapping CNV regions (CNVRs) by
aggregating CNVs that overlap by at least 1 bp. The
Ensembl genes (release 76) overlapping with these
CNVRs were extracted using custom PERL scripts. Gene
ontology (GO) and Kyoto Encyclopedia of Genes and
Genomes (KEGG) analysis were performed in Database
for Annotation, Visualization and Integrated Discovery
(DAVID, ver 6.7) [26].
Comparison with previous CNV discovery studies and
gene expression studies
Since most of previous CNV detection studies using the
same two chicken lines were based on the Galgal3
genome assembly, coordinates of the CNVRs were con-
verted using NCBI Remap (http://www.ncbi.nlm.nih.gov/
genome/tools/remap). The minimum ratio of bases that
must be remapped was set to 0.5, and the maximum ratio
for difference between source length and the target length
was set to 5.0. At the same, we also allow multiple
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locations to be returned and fragments to be merged. In
terms of selecting the best remap results, the following
criteria was applied: a) the coverage was closest to 1.0; b)
the top hit was retained; and 3) results that contained
“random” or “NULL” were discarded. CNVRs overlapped
reciprocally at least 1 bp were considered cross-validated.
The transcripts with altered expression after MDV
infection identified by ASE screening were obtained
from Perumbakkam et al. [27] (Supplemental Table 7).
Duplicate transcripts were removed, and then the coor-
dinates based on Galgal4 assembly were obtained for the
transcript IDs.
To access whether the overlap between fixed CNVRs and
ASE genes is statistically significant, we performed permuta-
tion test using R statistical package [28]. Specifically, we gen-
erated randomly distributed CNVs of the same sizes as the
tested CNVs by simulation. The number of overlap in each
simulation was calculated and the empirical distribution of
hits was obtained by 10,000 independent simulations. The
significance of overlap was determined by setting the thresh-
old according to the empirical distribution.
Validation by PCR assay
In addition, PCR experiments to validate a subset of the
CNV results were performed. Primers were designed by
Primer Premier5 (Premier Biosoft., Palo Alto, CA, USA)
[29] to amplify the entire CNVR. PCR reactions were con-
ducted in a 20 ul volume containing 15–30 ng genomic
DNA, 2–4 uM forward and backward primers, and 33–35
thermal cycles. The resultant amplicons were examined by
agarose gel electrophoresis (concentration: 1.0 %).
Availability of supporting data
The raw sequence data has been submitted to NCBI
Sequence Read Achieve (SRA) under the Bioproject
number of PRJNA280243. The Biosample numbers for
the sequenced samples are SAMN03459116 (RES1),
SAMN03438107 (RES2), SAMN03438108 (RES3),
SAMN03459118 (SUS1), SAMN03459119 (SUS2),
SAMN03459120 (SUS3), respectively.
Results
Read mapping and CNV detection
On average, ~236 million raw reads were generated for
each sample, and after quality control, ~213 million
reads were successfully aligned to the reference genome.
The sequencing depths calculated from mapped reads
were 20.5× and 20.0× for the resistant and susceptible
lines, respectively (Table 1). To minimize false positives,
we only used Q20 reads (effective reads, [21]) for further
analysis. The average genomic coverage by Q20 reads
was 95.1 %, which resulted in 19.6× and 18.8× on aver-
age coverage for the resistant and susceptible lines,
respectively (Table 1).
A total of 57,824 CNVs were identified by CNVnator
in these two lines, and 8,135 unique CNVs with different
start or end coordinates passed our stringent filtering
criteria (Additional file 1: Table S1). The size of these
CNVs ranges from 1 to 543.5 kb, with an average of
8.4 kb. As the operational definition of a CNV become
smaller in size due to the use of next generation sequen-
cing, we also used Pindel to detect smaller structural
variations. This analysis yielded 3,697 unique deletions
after filtering according to our criteria, which ranged in
size from 100 to 32,628 bp, with an average of 4.6 kb.
On average, each chicken line harbors 3,351 CNVs. Ag-
gregating overlapping CNVs resulted in 3,241 and 3,697
CNVRs for CNVnator and Pindel, respectively. Each of
these two approaches seem to capture a portion of the
whole structural variation, as about 30.9 % of CNVnator’s
results and 21.6 % of Pindel’s results overlapped with the
other. After combing the two datasets together, a collect-
ive set consisting of 5,680 CNVRs were obtained, which
are distributed over all chromosomes and two linkage
groups (LGE22C19W28_E50C23 and LGE64) (Additional
file 1: Table S1). The minimum CNVR was 102 bp and the
maximum was 543,600 bp, with an average of 5,096 bp
and together, these CNVRs affected 29.41 Mb, which en-
tails 2.76 % of the chicken genome. The CNVRs belonging
to loss, gain, or both account for 90.4 %, 7.6 % and 2.0 %,
respectively. The number of CNVRs in each chicken was
2,807 in RES1, 2,731 in RES2, 3,040 in RES3, 2,831 in
SUS1, 2,928 in SUS2, and 3,079 in SUS3.
Table 1 Statistics of sequencing and read mapping for each chicken
Chickena Line Raw reads After QC (Ratio, %) Mapped reads (Ratio, %) Q20 Reads (Ratio, %) Effective depth (X)b Q20 Coverageb (%)
RES1 63 205,596,588 187,877,511(91.3) 186,810,961(99.4) 176,987,396(94.2) 16.8 94.8
RES2 63 234,886,526 207,580,222(88.4) 206,152,608(99.3) 193,530,549(93.2) 18.4 95.0
RES3 63 286,301,462 256,953,147(89.8) 255,430,372(99.4) 241,909,593(94.1) 23.5 95.0
SUS1 72 233,281,700 213,717,896(91.6) 212,018,941(99.2) 195,175,544(91.3) 18.6 95.4
SUS2 72 222,031,616 204,055,933(91.9) 202,806,267(99.4) 190,921,220(93.6) 18.2 95.3
SUS3 72 236,881,356 220,680,041(93.2) 219,476,108(99.5) 207,828,724(94.2) 19.8 94.9
aRES resistant, SUS susceptible; b Calculated based on Q20 reads
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Validation
Cross-validation with previous studies
About 93.7 % of Crooijmans et al.’s [30] and 44.4 % of
Luo et al.’s [31] CNVs could be successfully converted to
the Galgal4 assembly (Additional file 2: Table S2 and
Table S3). The mean sizes of successfully converted
CNV were 62.1 kb (vs. 60.4 kb before conversion) and
43.7 kb (vs. 44.9 kb before conversion), respectively. We
obtained 346 and 32 CNVRs respectively for compari-
son. About 36.4 % of Crooijmans et al.’s [30] and 59.4 %
of Luo et al.’s results [31] can be validated by our study.
Taken together, 6.0 % of our CNVs overlapped with
these two previous studies, and in terms of involved
bases, this percentage rose to 26.1 % (Table 2; Additional
file 2: Table S4).
Validation by PCR assay
We selected four CNVs (deletions, CNVR2365, CNVR2772,
CNVR3265 and CNVR5213) and performed PCR validation
on the sequenced chickens (primer information was pro-
vided in Additional file 3: Table S5). For most of the dele-
tions in our studies, the CNVs are zero copies because of
the highly homozygous genetic background. Therefore, the
CNV status could be easily identified as presence or absence
of PCR product through electrophoresis. The PCR results
correspond well with the sequencing results (Fig. 1).
CNVRs on GGA16
In chicken, GGA16 has higher interest for disease resist-
ance as it contains the major histocompatibility complex
(MHC), the key regulator of the immune system. While
the two chicken lines differ significantly in resistance to
MD, they share the same MHC haplotype (B2) [17, 19].
Therefore, the resistance difference between the two
lines is believed to be attributed to non-MHC loci. To
test this assumption, sequence variation of this chromo-
some was examined. Twenty CNVRs were found in this
chromosome, 8 of which (CNVR4443-4450) overlapped
with previous findings (Table 3). The CNVRs overlapped
with several MHC genes including BF1, BLEC2, TRIM
family (TRIM1, TRIM27.2, and TRIM7.1) and BG. No
CNVs were detected in BL loci. It should be noted that
nearly all CNVRs were found in only one chicken per line.
Line-specific CNVRs
Taken together, the majority of our CNVRs (71.3 %)
were found in more than one chicken (Additional file 1:
Table S1). And separately, about 72.2 % and 66.4 % of
the CNVRs were shared by at least two individuals for
resistant and susceptible lines, respectively. About 40 %
of the CNVRs were shared by both lines (Fig. 2a). The
CNVs unique to one line are of particular interest
because they probably contribute to the unique genetic
characteristics between the two lines, i.e., resistance to
MD. We defined line-specific CNVRs as those found in
one line while not in the other line, and obtained 1,546
(~3.62 Mb) and 1,866 (~7.03 Mb) line-specific CNVRs
in the resistant and susceptible lines, respectively (Fig. 2a,
Additional file 1: Table S1). Among the line-specific
CNVRs, 559 and 624 CNVRs have been fixed in resist-
ant and susceptible line, respectively. Over half of these
line-specific CNVRs were shared by two or more chick-
ens within the line (Fig. 2b). The mean CNVR size for
the lines 63 and 72 were 2,340 bp and 3,766 bp, respect-
ively, which was significantly different (P = 5.78e-10).
Perumbakkam et al. [27] identified a number of genes
showing allele-specific expression using RNA-seq. Further
work by Cheng et al. [11] demonstrated that variations of
these genes account for as much as 83 % of the additive
genetic variation in MD resistance. Thus these genes are
strong candidates of underlying genes of resistance or sus-
ceptibility to MD. To further explore the potential associ-
ation of our line-specific CNVRs with MD resistance, we
compared the line-specific CNVRs of high frequency
(shared by two or three individuals within the line) with
those ASE genes. A total of 803 transcripts were retained
Table 2 Cross-validation with previous CNV discovery studies in the same populationa
Studies Platform Reference Samples CNVR
countb
CNVR size (kb) Overlap with this study
Total Mean Max Min CNVR # Pct.c Overlap size (kb) Pct.d
This study Next generation
sequencing
Galgal4 6 5,680 29,410 5 544 0.1
Crooijmans et al. [30] Agilent 244 K
aCGH chip
Galgal3 10 346 18,908 55 5,321 3 126 36.4 6,981 36.9
Luo et al. [31] NimbleGen
385
k aCGH chip
Galgal3 4 32 1,399 44 190 10 19 59.4 694 49.6
Cumulatede - - - 19,379 53 53 3 145 38.4 7,714 39.6
aThe comparison was based on Galgal4 assembly
bThe CNVRs were obtained by aggregating overlapping CNVs that were successfully converted to Galgal4 assembly
cThe percentage was calculated by dividing the number of overlapped CNVRs by the total number of CNVRs in corresponding study
dThe percentage was calculated by dividing the number of overlapped bases by the total bases affected by CNVs in corresponding study
eA union set based on previous studies
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for comparison (Additional file 4: Table S6). The analysis
reveals that 67 (3.8 %) CNVRs overlapped with 62 (7.7 %)
ASE genes (Additional file 4: Table S7). Simulation test
was conducted to examine the significance of the overlap.
We use 10,000 simulations to build the empirical distribu-
tion of overlaps (Fig. 3). The results showed that only 68
cases out of 10,000 independent sets exceeded the thresh-
old. Therefore, our fixed CNVs have significant overlaps
with the ASE genes (P = 0.0068).
Gene content analysis
A total of 399 and 409 Ensembl genes were found to
overlap the CNVRs fixed within resistant and susceptible
line, respectively. We performed GO and KEGG path-
way analyses to explore the functions of these genes. GO
analysis reported 51 terms for the resistant line, 36 of
which were significant (Additional file 5: Table S8).
These significant terms are involved in Rab GTPase ac-
tivity, synapse and calcium channel activity, etc. For the
susceptible line, 34 out of the 65 reported terms were
significant (Additional file 5: Table S9). The genes are
enriched in the molecular functions of protein kinase ac-
tivity, binding activities, and transcription regulations.
Also, KEGG analysis reveals several pathways for the
susceptible line, among which the MAPK signaling
pathway is significantly enriched (Additional file 5:
Table S9; Fig. 4).
Discussion
MD is the only tumor disease that can be prevented by
vaccination in poultry, and has been used as a model for
human tumor study [1]. Understanding the genetic basis of
host resistance to MD is important not only for breeding
resistant chickens, but also providing clues for human
studies on similar complex diseases. A variety of genetic
and genomic strategies has been taken to study the mech-
anism of resistance to MD [4–6, 27, 32, 33] and success-
fully identified several candidate genes [34]. However, the
causative variations remains poorly understood. CNV is in-
creasingly recognized as an important yet not fully studied
Fig. 1 PCR validation of CNVRs. The PCR products were examined in 1 % agarose gel. M: marker (200 bp for CNVR2365,3265 and 2772; 100 bp for
CNVR5213); R1-R3: the three sequenced samples in line63; S1-S3: the three sequenced samples in line72
Table 3 Line-specific CNVRs on GGA16
CNVR ID Start End Size (bp) Status Line Sample Overlap CNVs Overlap genes
CNVR4435 107501 108600 1100 Loss 72 SUS1 NA ENSGALT00000000188




CNVR4438 171001 172600 1600 Loss 72 SUS1 NA NA
CNVR4439 177101 179200 2100 Loss 72 SUS1;SUS2 NA ENSGALT00000000149
CNVR4441 186601 189200 2600 Loss 63 RES1 NA ENSGALT00000000149
CNVR4444 235134 251820 16687 Loss 72 SUS1 Crooijmans et al. [30] ENSGALT00000003794;
ENSGALT00000043371
CNVR4447 402401 405200 2800 Loss 72 SUS3 Crooijmans et al. [30]; Luo et al. [31] ENSGALT00000001702
CNVR4448 408901 412800 3900 Gain 63 RES1 Crooijmans et al. [30]; Luo et al. [31] ENSGALT00000041340
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type of genetic variation. Extensive CNV discovery studies
have been conducted in chicken [24, 30, 31, 35–40], but
studies evaluating the association between CNVs and
complex traits have been sparse [31, 40].
In this study, we hypothesized that some common
CNVs within population contribute to the resistance to
MD. We performed genome-wide survey of CNVs in
two well-known inbred chicken lines that differ in sus-
ceptibility to MD by next generation sequencing, in
order to find some CNVs associated with the resistance
variation to MD. Using two distinct analytical approaches,
we identified a broad range of CNVs, ranging in size from
102 bp to 543,500 bp. The results from the two analyses
showed partial overlap most likely because of the differ-
ences in declaring variants as well as differences in the size
range of detected CNVs (8.4 kb vs 4.6 kb, on average). It is
well established that no single algorithm can capture the
entire spectrum of CNVs and results from different
approaches are most likely complementary to each other
[16, 23, 41, 42].
Fig. 2 Summary of line-specific CNVRs. a: Line-specific and shared CNVRs in the two chicken lines. b: The percentage of line-specific CNVRs with
different frequencies. The number after “Shared” denotes the number of chickens where this CNVR was found
Fig. 3 Empirical distribution of the number of overlapped random CNVs with ASE genes. Simulations are performed to test the significance of
the overlap between line-specific CNVRs and ASE genes. The vertical axis shows the counts of overlap numbers in 10,000 independent simulations
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Empowered by next generation sequencing, the reso-
lution of CNVs in this study is much higher than those
declared in previous studies [30, 31]. While only over
one-third of previous CNVs could be validated in our
studies, reasons for the relatively small overlap could be
attributed to several aspects: first, not all previous CNVs
were successfully converted for comparison; second, the
CNV sizes from Crooijmans et al. [30] and Luo et al.
[31] are very large, whereas the mean size of CNVs from
both CNVnator and Pindel in this study are much
smaller. Only the largest CNVs are in the same size
order of magnitude with previously identified CNVs,
making it not directly comparable; third, some of the
CNVs are private or rare variations. We selected four
CNVs for PCR experiments to investigate the reliability
of our results, all of which have not been reported by
any of previous studies in the same population. The
results confirmed that these CNVs are true variations,
demonstrating that the results are reliable.
We observed that globally and separately, most of our
CNVRs were shared by more than one individual. This
is in sharp contrast with our previous findings from diverse
chicken breeds, where most CNVRs were found only in
one sample [24, 39]. The reduced diversity can be explained
by the homogeneous genetic background due to highly
inbreeding. The two chicken lines have been continuously
inbred for decades, with the inbreeding coefficients within
lines exceeding 99 % [17]. Nearly 40 % of the identified
CNVRs were shared by the two lines, indicating that these
events existed in the common ancestor, since the two lines
shared some sires and dams in the initial stage [17]. The
lineage-specific CNVRs may represent new events after the
two lines’ divergence. Over 52 % of the line-specific CNVRs
were fixed or nearly fixed within the same line, indicating
Fig. 4 MAPK signaling pathway in CNVRs unique to the susceptible line
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that the common variation contributed more than private
variation to the line-specific characteristics.
Variation on MHC
Among the potential loci responsible for the resistance
to MD, the MHC is no doubt a major locus with signifi-
cant influence [43, 44]. Historically, the two chicken
lines were believed to share the same MHC haplotype
(B2) as determined serologically by erythrocyte agglutin-
ation tests and graft transplantation [17, 45]. Therefore,
the resistance difference between the two lines is attrib-
uted to non-MHC loci. We inspected the copy number
state of the MHC loci between the two lines to evaluate
whether variation of copy number in certain regions
contribute to the resistance difference. As many as 20
CNVRs were observed, 8 of which could be validated by
different platforms. These findings provide additional ev-
idences that the MHC loci are highly polymorphic, even
in such highly inbred lines. From the point of evolution,
it is advantageous for the population to maintain a rela-
tive high degree of diversity in the MHC loci in the con-
text of changing circumstance. However, it is difficult
to associate these CNVs with the resistance to MD
according to our “common variant-disease” assumption,
because most of these CNVs were private, rather
than population-specific. The only line-specific CNVR
(CNVR4439) shared by two chickens overlapped with the
TRIM7.1 gene. TRIM7.1 encodes a member of tripartite
motif (TRIM) families which are involved in a wide range
of cellular processes and are important regulators of car-
cinogenesis and tumor regression [46]. However, whether
TRIM family plays a role in viral infection with regard to
MDV remains unknown [47].
Integration analysis
We performed pathway analysis to investigate whether
genes affected by the line-specific CNVRs involved in
specific pathways or biological processes. We found the
genes overlapped CNVRs unique to the susceptible line,
including EGF, CACN and MKK4 were significantly
enriched in MAPK signaling pathway. MAPK pathway is
one of the most extensively studied pathways involved in
tumorgenesis [48] and has proven to be a major target
of Meq during tumor formation by chromatin immuno-
precipitation sequencing [49] and RNA sequencing [50].
The fact that the enrichment of genes in MAPK signaling
pathway was corroborated by different strategies indicates
that the MAPK signaling pathway plays an important role
in host resistance to MD.
The role of CNVs in host resistance to MD
Gene expression is crucial for many biological processes,
and variation in transcriptional level plays a key role in
determining the phenotypic variation [51]. Recently,
genome-wide association studies of resistance to MD
from Cheng et al. [11] found that more than 83 % of the
additive genetic variance in MD resistance was captured
by the ASE SNPs, demonstrating that variation in MD
resistance are probably controlled by regulation of gene
expression, and most of the ASE genes are strong candi-
dates of underlying genes. CNVs are known able to alter
gene expression, and it has been shown that CNVs con-
tributed ~18 % of the genetic variation to gene
expression [52]. Thus, we examined whether our line-
specific CNVs affect some of the ASE genes and found
62 (~8 %) overlapped genes. Even though the overlap is
relatively small, it has strong statistical support. It can be
speculated that some of these ASE genes contribute to
the variation of disease resistance through a CNV manner.
However, if we assume the ASE genes are underlying
genes, one may wonder the reason for the relatively small
amount of overlap. One explanation is that, CNVs and
SNPs have complementary roles in determining the
phenotypic variation, and some of these CNVs may
contribute to the remaining 20 % genetic variation in MD
resistance not captured by ASE SNPs, making it not
directly comparable. As a complex trait, the susceptibility
to MD cannot be fully explained by the variation of a few
genes, but rather tens or hundreds, or even thousands of
genes with small to intermediate effects. Integrating differ-
ent sources of genetic variation for functional studies is a
reasonable approach to better understand the genetic
basis for complex traits [53].
It should be pointed out that, the two chicken lines
used in this study are highly inbred and the effective
population sizes of both populations are limited. There-
fore, some of these line-specific (or fixed) CNVs are gener-
ated simply due to random factors, such as genetic drift
during the divergence of the two lines. These CNVs are
probably functionally neutral and contribute little to the
resistance or susceptibility to MD. However, it is beyond
the scope of our study to distinguish these CNVs from
others as the aim of this study is to provide a broad pic-
ture of the CNVs in the genomes of the two parental lines.
Future studies using intercross or backcross populations
with greater statistical power should address this issue.
Also, the candidate genes in CNVRs need more validation
to confirm whether CNVs play a role in determining the
resistance or susceptibility to MD.
Conclusions
In summary, we sequenced three chickens from each of
the two chicken lines with different susceptibility to MD
and performed an initial screening of CNVs in the ge-
nomes of the two parental lines that potentially involved
in MD resistance. A number of line-specific CNVs were
identified, most of which were fixed or nearly fixed.
Pathway analysis of the genes affected by fixed CNVs
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provides additional lines of evidence that MAPK signal-
ing pathway may play an important role in host response
to MDV infection. Integration with functional loci iden-
tified previously reveals some CNVs potentially involved
in the host response to MDV infection through altering
gene expression levels. Our study provides additional in-
sights into the genetic and genomic architecture of the two
chicken lines, and the CNVs, especially the line-specific
CNVs are valuable resources for future association studies.
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Additional file 1: Table S1. Summary of identified CNVs and CNVRs in
the two chicken lines. For CNVs reported by CNVnator, the copy number
denoted the absolute copy number estimated by CNVnator, and for
those predicted by Pindel, the absolute copy number was not available
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